metaPreg - Ondansetron during pregnancy

Ondansetron

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	1.04 [0.96, 1.12]	43%	8 studies	167,592	116,161	not evaluable	unclear
Cleft lip with or without cleft palate	1.03 [0.88, 1.21]	0%	7 studies	4,585	92,238	not evaluable	unclear
Congenital heart defects	1.13 [0.96, 1.33]	66%	6 studies	59,616	116,155	not evaluable	unclear
Major congenital malformations	1.02 [0.99, 1.05]	0%	7 studies	150,947	115,320	not evaluable	unclear
Ventricular septal defect	1.13 [0.99, 1.27]	25%	7 studies	19,110	96,086	not evaluable	unclear
Cleft palate	1.26 [0.87, 1.82]	65%	6 studies	3,363	91,261	not evaluable	unclear
Atrial septal defect	1.05 [0.79, 1.39]	84%	5 studies	5,715	91,265	not evaluable	unclear
Atrioventricular septal defect	1.38 [0.65, 2.93]	73%	4 studies	6,190	90,765	not evaluable	unclear
Hypospadias	0.90 [0.70, 1.15]	0%	5 studies	3,323	1,874	not evaluable	unclear
Oro-facial clefts	1.20 [1.02, 1.40]	0%	4 studies	3,506	113,549	not evaluable	unclear
Club foot / Talipes equinovarus	1.09 [0.83, 1.44]	0%	4 studies	1,061	2,714	not evaluable	unclear
Limb defects	1.02 [0.92, 1.11]	0%	4 studies	8,425	90,330	not evaluable	unclear
Urinary malformations	1.23 [1.03, 1.46]	0%	4 studies	8,865	91,075	not evaluable	unclear
Ano-rectal atresia and stenosis	0.79 [0.49, 1.27]	0%	3 studies	671	1,881	not evaluable	unclear
Atresia or stenosis of other parts of small intestine	0.97 [0.61, 1.53]	0%	3 studies	394	1,880	not evaluable	unclear
Coarctation of aorta	0.95 [0.69, 1.29]	0%	3 studies	844	1,903	not evaluable	unclear
Craniosynostosis	1.13 [0.95, 1.35]	0%	3 studies	12,765	2,512	not evaluable	unclear
Diaphragmatic hernia	1.70 [1.17, 2.48]	0%	3 studies	875	2,394	not evaluable	unclear
Gastroschisis	0.89 [0.61, 1.29]	0%	3 studies	959	1,894	not evaluable	unclear
Hypoplastic left heart	1.49 [1.03, 2.17]	0%	3 studies	838	1,539	not evaluable	unclear
Pulmonary valve stenosis	1.08 [0.79, 1.48]	0%	3 studies	1,025	1,913	not evaluable	unclear
Severe congenital heart defect	0.76 [0.63, 0.93]	0%	2 studies	1,880	88,851	not evaluable	unclear
Single ventricle	0.90 [0.34, 2.37]	71%	2 studies	424	88,706	not evaluable	unclear
Total anomalous pulm venous return	0.84 [0.55, 1.30]	0%	2 studies	502	88,705	not evaluable	unclear
Abdominal wall defects	0.98 [0.90, 1.07]	0%	2 studies	8,816	89,679	not evaluable	unclear
Bilateral renal agenesis including Potter syndrome	1.85 [1.13, 3.02]	0%	2 studies	161	1,630	not evaluable	unclear
Cardiac septal defects	1.57 [1.17, 2.12]	43%	2 studies	39,475	2,528	not evaluable	unclear
Congenital cataract	0.94 [0.46, 1.91]	0%	2 studies	211	1,494	not evaluable	unclear
Digestive system anomalies	0.93 [0.85, 1.02]	0%	2 studies	9,598	89,700	not evaluable	unclear
Eye defects	0.95 [0.69, 1.30]	0%	2 studies	772	89,700	not evaluable	unclear
Genital anomalies	1.06 [0.97, 1.17]	0%	2 studies	7,100	89,679	not evaluable	unclear
Limb reduction defects	1.01 [0.39, 2.58]	0%	2 studies	563	2,115	not evaluable	unclear
Nervous system anomalies	0.94 [0.81, 1.09]	0%	2 studies	3,496	89,679	not evaluable	unclear
Oesophageal atresia with or without tracheo-oesophageal fistula	0.71 [0.40, 1.28]	0%	2 studies	364	1,496	not evaluable	unclear
Respiratory system anomalies	1.13 [1.01, 1.27]	0%	2 studies	3,951	89,679	not evaluable	unclear
Spina bifida	1.24 [0.83, 1.83]	0%	2 studies	461	620	not evaluable	unclear
Transposition of the great vessels	0.80 [0.52, 1.23]	0%	2 studies	584	649	not evaluable	unclear
Ear malformations	1.67 [1.17, 2.38]	-	1 study	450	88,446	not evaluable	unclear
27 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
Preterm (< 37 weeks)	1.28 [0.76, 2.15]	79%	4 studies	8,576	3,213	not evaluable	unclear
Low birth weight (< 2500g)	1.04 [0.61, 1.77]	50%	3 studies	7,451	2,147	not evaluable	unclear
Small for gestational age (weight)	0.96 [0.69, 1.35]	67%	2 studies	50,664	2,047	not evaluable	unclear
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
Caesarean	1.63 [1.28, 2.07]	0%	2 studies	31,113	339	not evaluable	unclear
2 non statistically significant endpoints reported in only one study
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
Low Apgar score (< 7) (at 5 min)	1.89 [0.62, 5.75]	0%	2 studies	567	35	not evaluable	unclear
Neonatal medical care	1.21 [0.94, 1.55]	0%	2 studies	42,510	351	not evaluable	unclear
Persistent pulmonary hypertension	-	-	0 study
3 non statistically significant endpoints reported in only one study
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
Late intrauterine deaths (> 22 weeks)	1.11 [0.60, 2.05]	0%	4 studies	679	3,424	not evaluable	unclear
Early intrauterine death (< 22 weeks)	0.40 [0.32, 0.50]	0%	3 studies	642	3,095	not evaluable	unclear
4 non statistically significant endpoints reported in only one study
Neuro-developmental disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB
1 non statistically significant endpoints reported in only one study